Spotlight -

Downstream Processing|

Upstream Processing

Raymond Kaiser

Articles by Raymond Kaiser

Key Considerations in Biosimilars Development

ByJohn Carlsen,Sian Estdale,Raymond Kaiser,Raymond Donninger,Joe Bower

October 1st 2012

Understanding opportunities and challenges across all major phases of development.

Latest Updated Articles

Key Considerations in Biosimilars Development
Published: October 1st 2012 | Updated:

Trending on BioPharm International

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

Analytics, Automation, and Quality Driving the Next Era of Drug Development

© 2025 MJH Life Sciences^®

All rights reserved.